KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exact Sciences (EXAS) Shares Outstanding (Weighted Average) (2016 - 2025)

Exact Sciences has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $188.7 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.44% to $188.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $188.7 million through Dec 2025, up 2.44% year-over-year, with the annual reading at $188.7 million for FY2025, 2.44% up from the prior year.
  • Shares Outstanding (Weighted Average) was $188.7 million for Q4 2025 at Exact Sciences, roughly flat from $189.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $189.3 million in Q3 2025 and troughed at $169.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $180.2 million (2023), against an average of $179.8 million.
  • Year-over-year, Shares Outstanding (Weighted Average) rose 14.53% in 2021 and then increased 2.06% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $171.3 million in 2021, then grew by 2.92% to $176.4 million in 2022, then increased by 2.15% to $180.1 million in 2023, then increased by 2.25% to $184.2 million in 2024, then rose by 2.44% to $188.7 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Shares Outstanding (Weighted Average) are $188.7 million (Q4 2025), $189.3 million (Q3 2025), and $188.9 million (Q2 2025).